Mercachem logo voor websites

Update COVID-19:

The COVID-19 situation is currently impacting most of the globe, including Asia, Europe and North America. At all MercachemSyncom sites, we follow the recommendations of the local competent authorities as they are released. We have established a series of contingency measures aimed at reducing risks for our employees, their families and the MercachemSyncom Operations. These measures are proactively being reassessed at regular intervals and adapted as deemed appropriate.

The MercachemSyncom team is united and determined to face the situation with the energy, strength and passion that constitute one of our hallmarks.

Getting ready for phase 1 web


MercachemSyncom, in collaboration with Catalent Pharma Solutions, Leads To Development, and Citoxlab, is proud to organize a joint interactive workshop, "Getting Ready for Phase 1", in Paris on Thursday January 31, 2019. Our Director of Process Research, Dr. Eric Damen, will give a lecture on API development, covering all important aspects in the scale-up and production of new clinical candidates. In the afternoon, he will be available to meet attendees to discuss challenges that arise as their compounds move into the clinical stage of research.

“To avoid delays at this critical stage in development, it’s all about making the right choices at the start,” says Dr. Damen, who looks forward to sharing his knowledge with attendees.

This joint workshop is intended for scientists working at discovery-stage biotech companies with molecules that will soon progress to Phase 1 clinical trials.

Click here to find out more about this event.

Click here to register and advise if you have any specific dietary or building access requirements.